Artesunate combinations for treatment of malaria: meta-analysis
Authors:
- M AdjuikMAM Adjuik
- A BabikerABA Babiker
- P GarnerP Garner
- P OlliaroPOP Olliaro
- W TaylorWTW Taylor
- N WhiteNWN White
- International Artemisinin Study GroupIGInternational Artemisinin Study Group
- 1 January 2004
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 363 (9402) , 9-17
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation
- Department for International Development
- Wellcome Trust
This publication has 18 references indexed in Scilit:
- Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trialThe Lancet, 2002
- Artesunate Reduces but Does Not Prevent Posttreatment Transmission ofPlasmodium falciparumtoAnopheles gambiaeThe Journal of Infectious Diseases, 2001
- Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trialThe Lancet, 2000
- Averting a malaria disasterThe Lancet, 1999
- Antimalarial drug resistance and combination chemotherapyPhilosophical Transactions of the Royal Society B: Biological Sciences, 1999
- Summing up evidence: one answer is not always enoughThe Lancet, 1998
- Effects of artemisinin derivatives on malaria transmissibilityThe Lancet, 1996
- Practical methodology of meta‐analyses (overviews) using updated individual patient dataStatistics in Medicine, 1995
- Treatment Of Multidrug-Resistant Plasmodium Falciparum Malaria With 3-Day Artesunate-Mefloquine CombinationThe Journal of Infectious Diseases, 1994
- Methods for combining randomized clinical trials: Strengths and limitationsStatistics in Medicine, 1987